Windtree Therapeutics (Nasdaq: WINT) Makes NASDAQ Top Gainers List on News of Istaroxime Clinical Development and Upcoming Clinical Trial Data
July 26, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a go-to platform for big investing ideas, including biotech stocks reports on trading for Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on…